Relay Therapeutics (RLAY) Cash from Operations (2019 - 2026)
Relay Therapeutics (RLAY) posted quarterly Cash from Operations of 51112000.0 for Q1 2026, up 30.18% year-over-year from 39261232.22 in Q1 2025, and down 13.92% quarter-over-quarter from 44865000.0 in Q4 2025.
Relay Therapeutics (RLAY) Cash from Operations (2019 - 2026) Analysis & Trends
Relay Therapeutics (RLAY) has reported Cash from Operations for 8 consecutive years, with 51112000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Cash from Operations rose 30.18% year-over-year to 51112000.0; the TTM figure through Mar 2026 stood at 213357000.0 (up 21.56% YoY), while the FY2025 annual figure was 235455000.0, up 5.48% from the prior year.
- Cash from Operations eased to 51112000.0 in Q1 2026 per RLAY's latest filing, from 44865000.0 in the prior quarter.
- Across five years, Cash from Operations topped out at 44865000.0 in Q4 2025 and bottomed at 89188000.0 in Q4 2023.
- Historically, Cash from Operations has averaged 62675294.12 across 5 years, with a median of 62119000.0 in 2025.
- Annual changes were most pronounced in 2022 — Cash from Operations tumbled 205.43% — and 2024, when it jumped 35.12%.
- Relay Therapeutics' Cash from Operations stood at 57079000.0 in 2022, then tumbled by 56.25% to 89188000.0 in 2023, then surged by 35.12% to 57868000.0 in 2024, then grew by 22.47% to 44865000.0 in 2025, then retreated by 13.92% to 51112000.0 in 2026.
- Business Quant data shows RLAY's Cash from Operations at 51112000.0 in Q1 2026, 44865000.0 in Q4 2025, and 62119000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 1.13 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 813.00 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -387.32 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 462.82 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -1.76 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 728.46 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 326.72 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -88.83 Mn |
| 10 | Relay Therapeutics | 4.34 Bn | 4.34 Bn | - | -54.11 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -54.11 Mn |
| Jun 30, 2026 | -54.11 Mn |
| Mar 31, 2026 | -51.11 Mn |
| Mar 31, 2026 | -51.11 Mn |
| Dec 31, 2025 | -44.87 Mn |
| Dec 31, 2025 | -44.87 Mn |
| Sep 30, 2025 | -62.12 Mn |
| Sep 30, 2025 | -62.12 Mn |
| Jun 30, 2025 | -55.26 Mn |
| Jun 30, 2025 | -55.26 Mn |
| Mar 31, 2025 | -73.21 Mn |
| Mar 31, 2025 | -73.21 Mn |
| Dec 31, 2024 | -57.87 Mn |
| Dec 31, 2024 | -57.87 Mn |
| Sep 30, 2024 | -75.08 Mn |
| Sep 30, 2024 | -75.08 Mn |
| Jun 30, 2024 | -65.83 Mn |
| Jun 30, 2024 | -65.83 Mn |
| Mar 31, 2024 | -50.32 Mn |
| Mar 31, 2024 | -50.32 Mn |